TERT and laryngeal neoplasm: Corroborating our results, Qu et al. (34) found TERT mutation associated with poor overall survival in laryngeal tumor patients (cases with TERT promoter mutations had 72.2 vs. 78.2 months for wild-type patients, p = 0.04).